We identified a set of genes including CTBP2, NADK, AZU1, CTSH, FSTL1, and HDLBP showing the highest accuracy more than 69.44 % to classify TKI response in CML patients. This evidence concerns the gene HDLBP and chronic myelogenous leukemia, BCR-ABL1 positive.